Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Pharmaceutical company completes level 1 American Depositary Receipts Program
February 10th, 2005
Starpharma Holdings Limited announced that it has completed establishment of a Level 1 American Depositary Receipts (ADR) Program. Under approval granted by the U.S. Securities Exchange Commission, investors can now purchase Starpharma ADRs on the U.S. over-the-counter market. Starpharma CEO John Raff described the ADR program as an important step to facilitate trading of Starpharma securities by U.S. nanotechnology investors. "Starpharma is the first company in the world to initiate FDA (U.S. Food and Drug Administration)-approved human clinical testing of a nanotech-based drug. We also have a substantial presence in U.S....
Source: Women's Health Weekly (2005-02-10)
|
